Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Free Cash Flow (2020 - 2025)

Roivant Sciences' Free Cash Flow history spans 6 years, with the latest figure at -$191.5 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 71.44% year-over-year to -$191.5 million; the TTM value through Dec 2025 reached -$593.5 million, up 47.59%, while the annual FY2025 figure was -$844.0 million, 10.1% down from the prior year.
  • Free Cash Flow reached -$191.5 million in Q4 2025 per ROIV's latest filing, up from -$193.5 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$123.4 million in Q3 2021 to a low of -$675.4 million in Q4 2022.
  • Average Free Cash Flow over 5 years is -$317.8 million, with a median of -$208.4 million recorded in 2025.
  • Peak YoY movement for Free Cash Flow: plummeted 199.26% in 2021, then surged 71.44% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$541.4 million in 2021, then decreased by 24.74% to -$675.4 million in 2022, then grew by 2.6% to -$657.8 million in 2023, then decreased by 1.95% to -$670.7 million in 2024, then soared by 71.44% to -$191.5 million in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Free Cash Flow are -$191.5 million (Q4 2025), -$193.5 million (Q3 2025), and -$208.4 million (Q2 2025).